Top Markets
#1 Islamic Coin Islamic Coin +155.94%
#2 Siren Siren +37.14%
#3 Arowana Arowana +19.76%
#4 RedStone RedStone +15.44%
#5 Cysic Cysic +15.30%
#6 Venom Venom +14.04%
#7 OpenEden OpenEden +13.54%
#8 Nockchain Nockchain +12.74%
#9 Perle Perle +11.94%
#10 KUB Coin KUB Coin +11.87%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Brainstorm Cell Therapeutics Inc. Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc.

BCLI
Classifica tra le azioni #31763
Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to... Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to the development and commercialization of personalized, autologous cellular therapies. These innovative treatments are specifically designed to address neurodegenerative diseases. At the heart of its strategy is the proprietary NurOwn cell therapy platform. This platform employs sophisticated cell culture techniques to prompt mesenchymal stem cells, derived from the patient's own bone marrow, to produce high concentrations of neurotrophic factors. This process aims to regulate neuroinflammatory and neurodegenerative disease mechanisms, bolster the survival of neurons, and ultimately enhance neurological function. NurOwn is currently undergoing significant clinical development, having completed a Phase III clinical trial for Amyotrophic Lateral Sclerosis (ALS). Additionally, it has successfully advanced through Phase II clinical trials for both progressive multiple sclerosis and Alzheimer's disease, with potential applications being explored for other neurodegenerative conditions. To support its therapeutic pipeline, the company has established a manufacturing partnership with Catalent for NurOwn. Incorporated in 2000, the company initially operated as Golden Hand Resources Inc. before adopting the name Brainstorm Cell Therapeutics Inc. in November 2004. Its corporate headquarters are situated in New York, New York.
Prezzo delle azioni
$1.10
Ultima sincronizzazione: 2026-08-17
Capitalizzazione di mercato
$12.14M
Variazione (1 giorno)
11.11%
Variazione (1 anno)
77.42%
Paese
US
Scambia Brainstorm Cell Therapeutics Inc. (BCLI)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Brainstorm Cell Therapeutics Inc. (BCLI)
L’azione Brainstorm Cell Therapeutics Inc. (simbolo: BCLI) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 18, 2026.
Una quota di BCLI acquistata prima di Aug 18, 2026 equivale oggi a 0 quote di BCLI.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR